Karl Kolter

This inventor holds 70 USPTO granted patents and 32 published patent applications, plus 3 CIPO patents and 44 EPO patents, primarily in Pharmaceutical Formulations (CPC class A61K). Top assignees: Basf Se Corporation, Basf Aktiengesellschaft, Knoll Aktiengesellschaft. Active years: 1997-2024.

USPTO Granted Patents = 70 (Patent Applications = 32)

% Patents Active = 84.3

CIPO Patents = 3

EPO Patents = 44 (Patent Applications = 55)

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 569(Granted Patents)

Forward Citations (Not Self Cited) = 539(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Limburgerhof, DE (1997 - 2024)
Ludwigshafen am Rhein, DE (2020 - 2024)
Ludwigshafen, DE (2021 - 2024)

Company Filing History:

Basf Aktiengesellschaft

patents

1 out of 84

Knoll Aktiengesellschaft

patents

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Pharmaceutical Formulations

Rapidly Disintegrating Tablets

Protective Coatings

Copolymers

Solid Solutions

Polymer Dispersions

Dust-Free Preparations

Film-Coating Compositions

Active Ingredient Delivery

Spherical Microparticles

Vitamin Preparations

Tablet Disintegrants

70 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12016926 - Terpolymers and their use in pharmaceutical dosage forms (2024-06-25),

2. 11993759 - Solid solutions of odoriferous substances and flavoring agents with vinyl lactam polymers (2024-05-28),

3. 11980218 - Dust-free cold-water-dispersible preparations (2024-05-14),

4. 11723871 - Poly(meth)acrylic acid popcorn polymerizates as disintegrants for tablets (2023-08-15),

5. 11491090 - Spherical microparticles with polyester walls (2022-11-08),

6. 11154508 - Dry-binders for tablets based on polyethylene glycol-polyvinyl alcohol graft polymers, the production and use thereof (2021-10-26),

7. 11123282 - Formulations with a controlled release of perfumes for dermal application (2021-09-21),

8. 10912835 - Production of pharmaceutical protective coatings with good resistance in a neutral environment (2021-02-09),

9. 10835456 - Propyl gallate-containing vitamin preparations (2020-11-17),

10. 10668156 - Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers (2020-06-02),

11. 10610487 - Salts of active ingredients with polymeric counterions (2020-04-07),

12. 10406105 - Pharmaceutical formulation for the production of rapidly disintegrating tablets (2019-09-10),

13. 10328150 - Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers (2019-06-25),

14. 9795576 - Protective coatings for acidic active ingredients (2017-10-24),

15. 9789065 - Process for producing oral dosage forms with controlled release (2017-10-17),

Title: Unveiling the Inventive Mind of Karl Kolter

Introduction:

Karl Kolter, a brilliant inventor hailing from Limburgerhof, Germany, has left a remarkable imprint in the world of patents and innovations with his prolific work.

Latest Patents:

Karl Kolter's latest patents showcase his expertise in pharmaceuticals and materials science, with inventions like "Poly(meth)acrylic acid popcorn polymerizates as disintegrants for tablets" and "Spherical microparticles with polyester walls".

Career Highlights:

With an impressive portfolio of 67 patents, Karl Kolter has made significant contributions to the field of pharmaceuticals and materials. He has honed his skills and knowledge while working at renowned companies such as BASF SE and BASF Aktiengesellschaft.

Collaborations:

Throughout his career, Karl Kolter has collaborated with esteemed professionals in the industry, including Maximilian Angel and Axel Sanner. Their combined efforts have led to groundbreaking inventions and advancements in various domains.

Conclusion:

In conclusion, Karl Kolter's innovative spirit and dedication to pushing the boundaries of science and technology have solidified his position as a prominent inventor in the global landscape. His contributions continue to inspire and shape the future of innovation in the pharmaceutical and materials industry.